Using immunoproteomics approach, we identified that DLD63-79 peptide derived from Leishmania major DLD, an important metabolic enzyme in the parasite, as a strong inducer of CD4+ T cell response in a mouse model of experimental cutaneous leishmaniasis [12]. This evidence concerns the gene CD4 and cutaneous leishmaniasis.